Takeda proposes $2.2-billion settlement to resolve Actos suits; Public Citizen says diabetes drugs are unlawfully promoted; PAIN study says 20% to 30% of opioid drugs are misused
Bristol-Myers Squibb licenses autoimmune program from Novo Nordisk
March 25, 2015
6:30 pm
The drugmaker inks deal with Novo Nordisk to access its biologic discovery research platform.